跳至主要内容
临床试验/NL-OMON53644
NL-OMON53644招募中不适用

The effects of cold-induced shivering at different intensities on 24-hour blood glucose profiles in pre-diabetic individuals and patients with type 2 Diabetes Mellitus - Shivering and Glucose Dynamics (SHIVER)

niversiteit Maastricht0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria for all subjects:
  • 1) Able to provide signed and dated written informed consent prior to any
  • study-specific procedures
  • 2) Have suitable veins for cannulation or repeated venipunture
  • 3) Be men or postmenopausal (at least 1 year post cessation of menses) females
  • 4) Aged between 40 - 75 years at the start of the study
  • 5) Have body mass index (BMI) >= 27 and <= 38 kg/m2
  • 6) Have stable dietary habits (no weight loss or gain > 5 kg within the past 3
  • 7) Have no signs of active cardiovascular disease or liver malfunction
  • Additional inclusion criteria for prediabetic subjects:
  • Pre-diabetes based on one or a combination of the following criteria:
  • - Impaired Glucose Tolerance (IGT): plasma glucose values >= 7.8 mmol/l and <=
  • 11.1 mmol/l 120 minutes after glucose drink consumption during OGTT in screening
  • - Impaired Fasting Glucose (IFG): Fasting plasma glucose >= 6.1 mmol/l and <= 6.9
  • - Insulin Resistance: glucose clearance rate <= 360 mL/kg/min, as determined
  • using OGIS120
  • - HbA1c of 5.7-6.4%
  • Additional inclusion criteria for Type 2 Diabetes Mellitus patients:
  • 1) Diagnosed with T2DM at least 1.5 years before the start of the study
  • 2) Have well-controlled diabetes at the time of screening, defined as HbA1c
  • levels < 8.5 %
  • 3) Have no signs of active diabetes-related co-morbidities, including active
  • cardiovascular diseases, diabetic foot, polyneuropathy or retinopathy
  • 4) Are on a diet treatment OR on an oral glucose lowering medication: metformin
  • only or in combination with sulfonylurea agents and/ or on stable dose of a
  • DPPIV inhibitor treatment for at least the last 3 months

排除标准

  • For all subjects:
  • 1) Not meeting the respective inclusion criteria
  • 2) Participation in a clinical study with an investigational product during the
  • last 3 months or as judged by the investigator
  • 3) Having uncontrolled hypertension
  • 4) Having Hb < 8 mmol/L (men) or Hb < 7 mmol/L (women)
  • 5) Consuming alcohol > 2 servings per day (men) or > 1 serving per day (women)
  • 6) Not wanting to be informed about unexpected medical findings during the
  • screening/ study
  • 7) Being engaged in structured exercise > 2h per week
  • 8) Smoking
  • 9) Being cold-acclimated, e.g. having taken daily extended cold baths, working
  • in a refrigerated environment, or practicing regular cold-water swimming/
  • showering within 1 month of starting the study
  • For pre-diabetic participants:
  • 1) Being previously diagnosed with Type 2 Diabetes Mellitus
  • For Type 2 Diabetes Mellitus patients:
  • 1) Being insulin-dependent

研究者

相似试验

The effects of cold-induced shivering at different... | 临床试验